Reuters: Amgen To Buy Onyx For $10.4B
Investors reacted favorably on Monday to Amgen Inc's $10.4 billion purchase of Onyx Pharmaceuticals Inc, which gives the world's largest biotech company full rights to a blood cancer drug with multibillion-dollar sales potential.
26 August 2013•2 mins read
